Bone marrow stem cell protection from chemotherapy by low–molecular-weight compounds
- 28 February 2001
- journal article
- review article
- Published by Elsevier in Experimental Hematology
- Vol. 29 (2) , 123-137
- https://doi.org/10.1016/s0301-472x(00)00621-4
Abstract
No abstract availableKeywords
This publication has 105 references indexed in Scilit:
- Engraftment of Hematopoietic Progenitor Cells Transduced with the Fanconi Anemia Group C Gene (FANCC)Human Gene Therapy, 1999
- High Plasma Level of N -Acetyl-Seryl-Aspartyl-Lysyl-ProlineHypertension, 1997
- Amifostine (WR-2721) Protects Normal Haematopoietic Stem Cells Against Cyclophosphamide Derivatives' Toxicity Without Compromising Their Antileukaemic EffectsEuropean Journal Of Cancer, 1995
- Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in miceAnnals of Hematology, 1995
- Diethyldithiocarbamate chemoprotection of carboplatin-induced hematological toxicityZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Cytokine Stimulation of Multilineage Hematopoiesis from Immature Human Cells Engrafted in SCID MiceScience, 1992
- Evaluation of the immunomodulatory potential of diethyl dithiocarbamate derivativesInternational Journal of Immunopharmacology, 1991
- Involvement of thymosin β4 and endoproteinase Asp‐N in the biosynthesis of the tetrapeptide AcSerAspLysPro a regulator of the hematopoietic systemFEBS Letters, 1990
- Regulation of Hemopoiesis by Bone Marrow Stromal Cells and Their ProductsAnnual Review of Immunology, 1990
- Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. Relationship to cell surface receptor.Journal of Clinical Investigation, 1986